Pasithea Therapeutics Corp Stock Price on September 13, 2024
| KTTA Stock | USD 3.18 0.01 0.31% |
If you're considering investing in Pasithea Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pasithea Therapeutics stands at 3.18, as last reported on the 22nd of November, with the highest price reaching 3.37 and the lowest price hitting 2.92 during the day. Pasithea Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0214, which implies the firm had a -0.0214% return per unit of risk over the last 3 months. Pasithea Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pasithea Therapeutics' Coefficient Of Variation of (4,951), variance of 85.23, and Risk Adjusted Performance of (0.01) to confirm the risk estimate we provide.
At present, Pasithea Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 34.3 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 1.2 M. . As of November 22, 2024, Price To Sales Ratio is expected to decline to 36.39. In addition to that, Price Earnings Ratio is expected to decline to -0.61. Pasithea Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Pasithea |
Sharpe Ratio = -0.0214
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KTTA |
Estimated Market Risk
| 9.44 actual daily | 84 84% of assets are less volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pasithea Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pasithea Therapeutics by adding Pasithea Therapeutics to a well-diversified portfolio.
Price Book 0.2268 | Enterprise Value Ebitda 2.9009 | Price Sales 42.1513 | Shares Float 802.6 K | Wall Street Target Price 2 |
Pasithea Therapeutics Main Headline on 13th of September 2024
Acquisition by Tiago Marques of 5000 shares of Pasithea Ther... by Tiago Marques
Filed transaction by Pasithea Therapeutics Corp Officer Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3
Pasithea Therapeutics Valuation on September 13, 2024
It is possible to determine the worth of Pasithea Therapeutics on a given historical date. On September 13, 2024 Pasithea was worth 3.85 at the beginning of the trading date compared to the closed value of 3.87. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pasithea Therapeutics stock. Still, in general, we apply an absolute valuation method to find Pasithea Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pasithea Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pasithea Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.95 | 3.96 | 3.80 | 3.95 | 11,132 | |
09/13/2024 | 3.85 | 3.92 | 3.85 | 3.87 | 3,594 |
| 3.91 | 3.98 | 3.87 | 3.92 | 2,062 |
| Backtest Pasithea Therapeutics | | | Pasithea Therapeutics History | | | Pasithea Therapeutics Valuation | Previous | Next |
Pasithea Therapeutics Trading Date Momentum on September 13, 2024
| On September 16 2024 Pasithea Therapeutics Corp was traded for 3.92 at the closing time. The top price for the day was 3.98 and the lowest listed price was 3.87 . The trading volume for the day was 2.1 K. The trading history from September 16, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 1.29% . The trading delta at closing time against the current closing price is 14.21% . |
Pasithea Therapeutics Fundamentals Correlations and Trends
By evaluating Pasithea Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pasithea Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pasithea financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pasithea Therapeutics Stock history
Pasithea Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pasithea is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pasithea Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pasithea Therapeutics stock prices may prove useful in developing a viable investing in Pasithea Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.2 M | 1.2 M | |
| Net Loss | -2 M | -1.9 M |
Pasithea Therapeutics Quarterly Net Working Capital |
|
Pasithea Therapeutics Stock Technical Analysis
Pasithea Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pasithea Therapeutics Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Pasithea Therapeutics Corp cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pasithea Therapeutics November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Pasithea Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pasithea Therapeutics shares will generate the highest return on investment. By undertsting and applying Pasithea Therapeutics stock market strength indicators, traders can identify Pasithea Therapeutics Corp entry and exit signals to maximize returns
Pasithea Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pasithea Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Pasithea Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pasithea to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (1.24) | |||
| Treynor Ratio | (0.34) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Pasithea Stock analysis
When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |